Subscribe

Cristina Gasparetto, MD

Articles by Cristina Gasparetto, MD

Cristina Gasparetto, MD

CARTITUDE Trials in Multiple Myeloma

ByCristina Gasparetto, MD,Keith Stewart, MD, ChB, MBA,Joseph Mikhael, MD,Sagar Lonial, MD,Nina Shah, MD

September 5th 2021

Experts discussed safety and efficacy data of cilta-cel for R/R MM from the CARTITUDE-1 and CARTITUDE-2 studies.

Investigational Agents in Relapsed/Refractory Myeloma

ByKeith Stewart, MD, ChB, MBA,Sagar Lonial, MD,Nina Shah, MD,Cristina Gasparetto, MD

September 3rd 2021

Experts discuss emerging agents in the pipeline for the treatment of RRMM; including BCMA-targeted bispecific antibodies.

Nina Shah, MD

Using CAR T Therapy in R/R Multiple Myeloma

ByNina Shah, MD,Joseph Mikhael, MD,Keith Stewart, MD, ChB, MBA,Sagar Lonial, MD, FACP,Cristina Gasparetto, MD

August 21st 2021

Nina Shah, MD, and other experts discuss the role of CAR T-cell therapy in relapsed/refractory multiple myeloma.

Latest Updated Articles

Uptake of Nononcology Gene Therapy Remains Slow in Hematology
Published: August 16th 2024 | Updated: August 19th 2024
Phase 3 Trial Seeks to Continue Supporting Arsa-Cel Gene Therapy for MLD
Published: March 18th 2024 | Updated: June 3rd 2024
Rapcabtagene Autoleucel Shows Promise for DLBCL in Updated Phase 2 Data
Published: December 7th 2024 | Updated:
Aimee C. Talleur, MD, on Predicting Response and Toxicity to Cell Therapy
Published: December 12th 2022 | Updated:
RPE Cell Therapy Shows Improvements in Early GA With AMD
Published: July 14th 2024 | Updated:
Multi-Characteristic Opsin Gene Therapy for Retinitis Pigmentosa Improves Multiple Measures of Vision
Published: May 18th 2023 | Updated:

© 2025 MJH Life Sciences^®

All rights reserved.